Bioprocess & Manufacturing

Conferences & Courses
Part One: Analytical Methodology and PTMs Part One: Analytical Methodology and PTMs
March 9-10, 2015 | Baltimore, MD
Analytical Methodology and PTMs will be taking place March 9-10, 2015.

Biotherapeutics Analytical Summit Biotherapeutics Analytical Summit
March 9-13, 2015 | Baltimore, MD
Following year-on-year success, Cambridge Healthtech Institute presents a three-part event taking place March 9-13, 2014 in Baltimore, MD focusing on Analytical Methodology and PTMs, Characterization & Compliance and Comparability for Biologics.

Part Two: Characterization & Compliance Part Two: Characterization & Compliance
March 10-11, 2015 | Baltimore, MD
This event covers advanced characterization technologies for a range of complex therapeutic proteins to provide a fuller understanding of the product, to ensure safety and efficacy, and to facilitate smooth and efficient interaction with the regulatory au

Life Science Media Library
Operational Excellence in Bioprocessing Operational Excellence in Bioprocessing
August 18, 2014 |
Ensuring quality in bioprocesses that complies with regulatory requirements and mitigates risk often results in very high bottom-line costs. Adopting best practices early in the development process and customizing these approaches to operational excellence from other highly competitive industries are currently taking place in biopharmaceutical production. This course provides both an overview of these approaches along with details about how they work, as well as case studies and data addressing how these innovations have been applied successfully in bioprocessing and the development of biopharmaceuticals. Appropriate regulatory guidance is also discussed.
Optimizing Media: Achieving Super Soup Optimizing Media: Achieving Super Soup
August 18, 2014 |
The “Optimizing Media” digital course provides a detailed overview of the process for successfully developing media for culturing cells, with an emphasis on providing optimal conditions for cell growth. The overview addresses media supplementation, the importance of amino acids, protein free media, and serum versus serum-free media. In addition, the digital course includes a discussion about developing a chemically-defined basal and feed media for fed-batch cell culture, which includes strategies for optimizing basal and feed media, and developing fed-batch platforms. This presentation also highlights the use of Design of Experiments (DoE) strategies for developing basal media.
Accelerated Stability Testing of Biologics Accelerated Stability Testing of Biologics
August 20, 2013 |
This digital course will aim to guide the researcher in designing studies for accelerated stability testing of biologics. The course will begin with basic underlying concepts governing protein drug product stability, and focus on design principles for meaning stress and accelerated stability testing of not only the protein of interest but also of excipients and primary packaging components. Strategies to handle complexities arising from their interactions will also be discussed.

Publications, Reports, & Whitepapers
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.
The New Generation of Antibody Therapeutics
The New Generation of Antibody Therapeutics: Current Status and Future Prospects, published by Insight Pharma Reports.
Engineering Next-Generation Therapeutic Proteins
By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of protein engineering. This report discusses new developments in therapeutic protein engineering and developments that are likely to occur through 2020.